Second Phase 3 Clinical Trial for CMT1A “Pleodrug” February 17, 2020March 23, 2020 DanLeave a comment After the setback of having to do a second Phase 3 clinical trial, Pharnext's ongoing drug trials for PXT3003 show positive results in people with CMT1A.